Trademark: 90658433
Word
LIPAGLYN
Status
Pending
Status Code
733
Status Date
Tuesday, February 20, 2024
Serial Number
90658433
Mark Type
4000
Filing Date
Tuesday, April 20, 2021
Published for Opposition
Tuesday, January 18, 2022

Trademark Owner History
Cadila Healthcare Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy

Trademark Events
Feb 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2024
Sou Extension 4 Granted
Feb 20, 2024
Sou Extension 4 Filed
Feb 20, 2024
Sou Teas Extension Received
Sep 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2023
Sou Extension 3 Granted
Sep 13, 2023
Sou Extension 3 Filed
Sep 13, 2023
Sou Teas Extension Received
Mar 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 14, 2023
Sou Extension 2 Granted
Mar 14, 2023
Sou Extension 2 Filed
Mar 14, 2023
Sou Teas Extension Received
Aug 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2022
Sou Extension 1 Granted
Aug 5, 2022
Sou Extension 1 Filed
Aug 5, 2022
Sou Teas Extension Received
Mar 15, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 18, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 18, 2022
Published For Opposition
Dec 29, 2021
Notification Of Notice Of Publication E-Mailed
Dec 13, 2021
Approved For Pub - Principal Register
Dec 13, 2021
Assigned To Examiner
Jul 28, 2021
New Application Office Supplied Data Entered
Apr 23, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24